
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4
Ke Mao, Ding Lei, Heng Zhang, et al.
International Journal of Oncology (2017) Vol. 51, Iss. 5, pp. 1521-1532
Open Access | Times Cited: 30
Ke Mao, Ding Lei, Heng Zhang, et al.
International Journal of Oncology (2017) Vol. 51, Iss. 5, pp. 1521-1532
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Long non-coding RNA MEG3 promotes cerebral ischemia-reperfusion injury through increasing pyroptosis by targeting miR-485/AIM2 axis
Ji Liang, Qiang Wang, Junqi Li, et al.
Experimental Neurology (2019) Vol. 325, pp. 113139-113139
Closed Access | Times Cited: 155
Ji Liang, Qiang Wang, Junqi Li, et al.
Experimental Neurology (2019) Vol. 325, pp. 113139-113139
Closed Access | Times Cited: 155
NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway
Xiaofeng Yin, Qiong Zhang, Zhuo‐Yu Chen, et al.
International Journal of Oncology (2018)
Open Access | Times Cited: 55
Xiaofeng Yin, Qiong Zhang, Zhuo‐Yu Chen, et al.
International Journal of Oncology (2018)
Open Access | Times Cited: 55
PAK4 in cancer development: Emerging player and therapeutic opportunities
Yixi Yuan, Hongyan Zhang, Danni Li, et al.
Cancer Letters (2022) Vol. 545, pp. 215813-215813
Closed Access | Times Cited: 24
Yixi Yuan, Hongyan Zhang, Danni Li, et al.
Cancer Letters (2022) Vol. 545, pp. 215813-215813
Closed Access | Times Cited: 24
PAK4, a target of miR-9-5p, promotes cell proliferation and inhibits apoptosis in colorectal cancer
Meihua Wang, Qianqian Gao, Yufang Chen, et al.
Cellular & Molecular Biology Letters (2019) Vol. 24, Iss. 1
Open Access | Times Cited: 40
Meihua Wang, Qianqian Gao, Yufang Chen, et al.
Cellular & Molecular Biology Letters (2019) Vol. 24, Iss. 1
Open Access | Times Cited: 40
miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets
Omidvar Rezaei, Kasra Honarmand, Saeedeh Nateghinia, et al.
Experimental and Molecular Pathology (2020) Vol. 117, pp. 104550-104550
Closed Access | Times Cited: 39
Omidvar Rezaei, Kasra Honarmand, Saeedeh Nateghinia, et al.
Experimental and Molecular Pathology (2020) Vol. 117, pp. 104550-104550
Closed Access | Times Cited: 39
Linc01234 promotes cell proliferation and metastasis in oral squamous cell carcinoma via miR-433/PAK4 axis
Deyu Liu, Xin-chun Jian, Pu Xu, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 29
Deyu Liu, Xin-chun Jian, Pu Xu, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 29
Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression
Darshan S. Chandrashekar, Balabhadrapatruni V. S. K. Chakravarthi, Alyncia D. Robinson, et al.
Oncogene (2020) Vol. 39, Iss. 20, pp. 4077-4091
Open Access | Times Cited: 25
Darshan S. Chandrashekar, Balabhadrapatruni V. S. K. Chakravarthi, Alyncia D. Robinson, et al.
Oncogene (2020) Vol. 39, Iss. 20, pp. 4077-4091
Open Access | Times Cited: 25
MicroRNA-598 Inhibits Cell Proliferation and Invasion of Glioblastoma by Directly Targeting Metastasis Associated in Colon Cancer-1 (MACC1)
Ning Wang, Yang Zhang, Huaxin Liang
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2018) Vol. 26, Iss. 8, pp. 1275-1283
Open Access | Times Cited: 26
Ning Wang, Yang Zhang, Huaxin Liang
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2018) Vol. 26, Iss. 8, pp. 1275-1283
Open Access | Times Cited: 26
Mir-485-5P As A Potential Biomarker and Tumor Suppressor in Human Colorectal Cancer
Yuqin Pan, Jian Qin, Huiling Sun, et al.
Biomarkers in Medicine (2020) Vol. 14, Iss. 3, pp. 239-248
Closed Access | Times Cited: 23
Yuqin Pan, Jian Qin, Huiling Sun, et al.
Biomarkers in Medicine (2020) Vol. 14, Iss. 3, pp. 239-248
Closed Access | Times Cited: 23
<p>LINC01224 Exhibits Cancer-Promoting Activity in Epithelial Ovarian Cancer Through microRNA-485-5p-Mediated PAK4 Upregulation</p>
Shujian Xing, Yaqi Zhang, Jing Zhang
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 5643-5655
Open Access | Times Cited: 23
Shujian Xing, Yaqi Zhang, Jing Zhang
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 5643-5655
Open Access | Times Cited: 23
<p>Long Noncoding RNA SNHG7, a Molecular Sponge for microRNA-485, Promotes the Aggressive Behavior of Cervical Cancer by Regulating PAK4</p>
Fei Wu, Yujie Sui, Yinhuai Wang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 685-699
Open Access | Times Cited: 22
Fei Wu, Yujie Sui, Yinhuai Wang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 685-699
Open Access | Times Cited: 22
Deciphering specific miRNAs in brain tumors: a 5-miRNA signature in glioblastoma
João Basso, Marco G. Paggi, Ana Fortuna, et al.
Molecular Genetics and Genomics (2022) Vol. 297, Iss. 2, pp. 507-521
Closed Access | Times Cited: 12
João Basso, Marco G. Paggi, Ana Fortuna, et al.
Molecular Genetics and Genomics (2022) Vol. 297, Iss. 2, pp. 507-521
Closed Access | Times Cited: 12
microRNA-744 is downregulated in glioblastoma and inhibits the aggressive behaviors by directly targeting NOB1.
Yifan Deng, Yue Li, Qi Fang, et al.
PubMed (2018) Vol. 8, Iss. 11, pp. 2238-2253
Closed Access | Times Cited: 18
Yifan Deng, Yue Li, Qi Fang, et al.
PubMed (2018) Vol. 8, Iss. 11, pp. 2238-2253
Closed Access | Times Cited: 18
Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme
Xiangping Xia, Fang Cao, Xiaolu Yuan, et al.
PeerJ (2019) Vol. 7, pp. e7974-e7974
Open Access | Times Cited: 17
Xiangping Xia, Fang Cao, Xiaolu Yuan, et al.
PeerJ (2019) Vol. 7, pp. e7974-e7974
Open Access | Times Cited: 17
MicroRNA‑485 targets MACC1 and inhibits cervical cancer cell proliferation and invasion
Shumei Wang, Yaqi Zhang, Shunping Yuan, et al.
Molecular Medicine Reports (2018)
Open Access | Times Cited: 14
Shumei Wang, Yaqi Zhang, Shunping Yuan, et al.
Molecular Medicine Reports (2018)
Open Access | Times Cited: 14
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma
Holly Holliday, Jessica Yang, Eoin Dodson, et al.
Molecular Therapy (2022) Vol. 30, Iss. 3, pp. 1119-1134
Open Access | Times Cited: 8
Holly Holliday, Jessica Yang, Eoin Dodson, et al.
Molecular Therapy (2022) Vol. 30, Iss. 3, pp. 1119-1134
Open Access | Times Cited: 8
<p>microRNA-605 directly targets SOX9 to alleviate the aggressive phenotypes of glioblastoma multiforme cell lines by deactivating the PI3K/Akt pathway</p>
Jianwu Jia, Jing Wang, Meifeng Yin, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 5437-5448
Open Access | Times Cited: 8
Jianwu Jia, Jing Wang, Meifeng Yin, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 5437-5448
Open Access | Times Cited: 8
MiR‐193‐3p attenuates the vascular remodeling in pulmonary arterial hypertension by targeting PAK4
Zhenhua Wu, Jie Geng, Yujuan Qi, et al.
Pulmonary Circulation (2020) Vol. 10, Iss. 4, pp. 1-12
Open Access | Times Cited: 8
Zhenhua Wu, Jie Geng, Yujuan Qi, et al.
Pulmonary Circulation (2020) Vol. 10, Iss. 4, pp. 1-12
Open Access | Times Cited: 8
microRNA‑485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a
Xueman Lyu, Ling Wang, Jia Lu, et al.
Oncology Reports (2019)
Open Access | Times Cited: 7
Xueman Lyu, Ling Wang, Jia Lu, et al.
Oncology Reports (2019)
Open Access | Times Cited: 7
MiR-199a/b-3p inhibits colorectal cancer cell proliferation, migration and invasion through targeting PAK4 and BCAR3
Junjie Hou, Xuguang Mi, Ning Liu, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 4
Junjie Hou, Xuguang Mi, Ning Liu, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 4
MicroRNA‑940 promotes cell proliferation and invasion of glioma by directly targeting Kruppel‑like factor�9
Dongzi Zhang, Puheng Hao, Lin Jin, et al.
Molecular Medicine Reports (2018)
Open Access | Times Cited: 5
Dongzi Zhang, Puheng Hao, Lin Jin, et al.
Molecular Medicine Reports (2018)
Open Access | Times Cited: 5
MicroRNA‑663 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells by directly targeting PAK4
Ying‐Ying Liu, Dan Jiao, Zhen Tian
Molecular Medicine Reports (2018)
Open Access | Times Cited: 5
Ying‐Ying Liu, Dan Jiao, Zhen Tian
Molecular Medicine Reports (2018)
Open Access | Times Cited: 5
Identification and characterization of differentially expressed miRNAs in HepG2 cells under normoxic and hypoxic conditions
Fanzhi Kong, Ran Wei, Ning Jiang, et al.
RSC Advances (2019) Vol. 9, Iss. 29, pp. 16884-16891
Open Access | Times Cited: 5
Fanzhi Kong, Ran Wei, Ning Jiang, et al.
RSC Advances (2019) Vol. 9, Iss. 29, pp. 16884-16891
Open Access | Times Cited: 5
Therapeutically actionable PAK4 is amplified, overexpressed and involved in bladder cancer progression
Darshan S. Chandrashekar, Balabhadrapatruni V. S. K. Chakravarthi, Alyncia D. Robinson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Closed Access | Times Cited: 2
Darshan S. Chandrashekar, Balabhadrapatruni V. S. K. Chakravarthi, Alyncia D. Robinson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Closed Access | Times Cited: 2
Linc01234 promotes cell proliferation and metastasis in oral squamous cell carcinoma via miR-433/PAK4 axis
Deyu LIU, Xin-chun Jian, Pu Xu, et al.
Research Square (Research Square) (2019)
Open Access | Times Cited: 1
Deyu LIU, Xin-chun Jian, Pu Xu, et al.
Research Square (Research Square) (2019)
Open Access | Times Cited: 1